Boothbay Fund Management’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-11,808
Closed -$671K – 2280
2026
Q2
$936K Sell
11,808
-64,763
-85% -$4.87M 0.01% 1136
2026
Q1
$5.75M Buy
76,571
+1,009
+1% +$79.6K 0.07% 281
2025
Q4
$5.98M Sell
75,562
-87,900
-54% -$6.62M 0.09% 244
2025
Q3
$10.7M Buy
+163,462
New +$7.98M 0.16% 148

Other funds holding IONS

Boothbay Fund Management's IONS Position: Q3 2026 in Review

Boothbay Fund Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2026, closing a stake of 11,808 shares — an estimated $671K sold.

Boothbay Fund Management first reported a position in IONS in Q3 2025 and held it in 4 quarters. The position peaked at $10.7M in Q3 2025. 448 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • Boothbay Fund Management reported no remaining Ionis Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 11,808 Ionis Pharmaceuticals shares in Q3 2026, an estimated $671K.
  • Boothbay Fund Management first reported a position in Ionis Pharmaceuticals in Q3 2025 and held it in 4 quarters.
  • Boothbay Fund Management's Ionis Pharmaceuticals position peaked at $10.7M in Q3 2025.
  • 448 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.